Oil molecules have a wide range of chemical properties.
They can be broken down into more complex compounds.
These compounds can then act on receptors in the body to make things like blood vessels, heart cells and nerves grow, heal and even become more efficient.
In other words, oil molecules can play a vital role in a range of health conditions, including heart disease, diabetes and obesity.
But the research team, led by Dr Peter Fenton, at the University of Liverpool, have now identified a compound in oil molecules that can potentially influence human health.
This compound, known as covalent oxygen-1 (COX-1), is able to activate a number of proteins that control blood vessels and make them more efficient and responsive.
This may be the reason why it is thought that oil cooking tempers, as well as other types of cooking, may increase your risk of cardiovascular disease, stroke and cancer.
Dr Fenton’s team used mice to test the impact of oil cooking oil on various types of blood vessels.
These were then subjected to a series of tests that included blood pressure, heart rate and glucose levels.
The results showed that the COX-2 protein, found in many types of cells, activated more blood vessels in the blood vessels of the mice, but also in the liver, pancreas and pancreases of the animals.
This finding suggested that the effects of oil-cooking-oil-related compounds were linked to activation of the COAX-2 gene.
This, the researchers believe, is a first step towards understanding how these compounds affect the body.
The research is published in the journal Nature.
They have also shown that the compound activates COX2 genes in the cells of humans.
This could mean that it may be possible to create a medicine that could affect the function of these genes.
“Our results suggest that the activation of COX1 in human cells is mediated by the COx2 gene, which may help to control COX response,” said Dr Fournier.
“The COX activation is a key step towards our understanding of the role of COx-2 in the regulation of health and disease.”
The study was funded by the Natural Environment Research Council (NERC) and the Department of Medical Research.
Further information: The researchers’ work was supported by grants from the Natural Environmental Research Council and the National Heart Foundation.
Dr Peter, a lecturer in molecular biology at the Institute of Molecular Biology at the Imperial College, London, and his colleagues are now looking to see if the compound could also have clinical benefits in humans.
They are currently studying how the compound interacts with other genes in order to develop a new drug.
The researchers believe that further work is needed to determine the effects the compound has on human hearts and blood vessels as well.
“We want to be able to see how the effect of the compound on human heart tissue and blood flow will impact on cardiovascular disease,” said Peter.
“It is also important to understand if the effect is specific to the human body or whether it might affect other organs or tissues.”
More stories from Northern Ireland: